Company
Headquarters: Purchase, NY, United States
Founded: 2002 in Dallas, Texas, U.S.
Employees: 4,335
CEO: Mr. Jason Nathanial Gorevic
$3.64 Billion
USD as of Jan. 1, 2023
Company | Market Cap (USD) |
---|---|
![]() |
$25.12 B |
![]() |
$17.56 B |
![]() |
$9.03 B |
![]() |
$8.38 B |
![]() |
$6.37 B |
Company | Market Cap (USD) |
---|---|
![]() |
$495.37 B |
![]() |
$461.85 B |
![]() |
$347.61 B |
![]() |
$304.61 B |
![]() |
$287.63 B |
Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions. It offers a range of programs and services, including primary and specialty care telehealth solutions, chronic condition management, expert medical services, mental health solutions, and platform and program services. The company serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. It offers its products and services under the Teladoc, Livongo, and BetterHelp brands. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. The company was incorporated in 2002 and is headquartered in Purchase, New York.
Teladoc Health, Inc. has the following listings and related stock indices.
Stock: NYSE: TDOC
Stock: BMV: TDOC
Stock: Bovespa: T2DH34
Stock: FSX: 4LL
Telemedicine, analytics
Founder(s): Byron Brooks Michael Gorton
Jason Gorevic (CEO) Mala Murthy (CFO) David Sides (COO)
Revenue: US$1.093 Billion (Fiscal Year Ended December 31, 2020)
Operating income: –US$506.421 Million (Fiscal Year Ended December 31, 2020)
Net income: –US$485.136 Million (Fiscal Year Ended December 31, 2020)
Total assets: US$17.755 Billion (Fiscal Year Ended December 31, 2020)
Total equity: US$15.883 Billion (Fiscal Year Ended December 31, 2020)